{
    "eid": "2-s2.0-84943234689",
    "title": "Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?",
    "cover-date": "2015-06-01",
    "subject-areas": [
        {
            "$": "Virology",
            "@code": "2406"
        },
        {
            "$": "Hepatology",
            "@code": "2721"
        }
    ],
    "keywords": [
        "Bile duct cancer",
        "Diagnosis",
        "Early detection",
        "Liver cancer",
        "Surveillance"
    ],
    "authors": [
        "Maria E. Lozada"
    ],
    "citedby-count": 9,
    "ref-count": 88,
    "ref-list": [
        "SEER Cancer Statistics Review",
        "International trends in liver cancer incidence rates",
        "Problem of hepatocellular carcinoma in West Africa",
        "Hepatocellular carcinoma review: Current treatment, and evidence-based medicine",
        "Update on the management of cholangiocarcinoma",
        "Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study",
        "Biliary tract cancers in olmsted county, Minnesota, 1976-2008",
        "Update on Biomarkers of Hepatocellular Carcinoma",
        "Phases of biomarker development for early detection of cancer",
        "Surveillance for hepatocellular carcinoma: Evidence, guidelines and utilization",
        "Management of hepatocellular carcinoma: An update",
        "\u03b1-Fetoprotein, Des-\u03b3 Carboxyprothrombin, and Lectin-Bound \u03b1-Fetoprotein in Early Hepatocellular Carcinoma",
        "Screening process failures for hepatocellular carcinoma.",
        "Randomized controlled trial of screening for hepatocellular carcinoma",
        "Improving screening for hepatocellular carcinoma by incorporating data on levels of \u03b1-fetoprotein, over time",
        "{A figure is presented}The Utility of Lens Culinaris Agglutinin-Reactive \u03b1-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: Evaluation in a United States Referral Population",
        "Des-\u03b3-Carboxy Prothrombin and \u03b1-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma",
        "The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers",
        "Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model.",
        "A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis",
        "Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model",
        "Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation",
        "Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: Refined selection criteria",
        "Pretransplantation \u03b1-fetoprotein slope and milan criteria: Strong predictors of hepatocellular carcinoma recurrence after transplantation",
        "Meta-analysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis",
        "Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis",
        "Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations",
        "Elevated plasma osteopontin levels in patients with hepatocellular carcinoma",
        "Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis",
        "Identification of osteopontin as a novel marker for early hepatocellular carcinoma",
        "Osteopontin and latent-TGF \u03b2 binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma",
        "Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells",
        "Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: A diagnostic meta- analysis",
        "Diagnostic accuracy of golgi protein 73 in primary hepatic carcinoma using ELISA: A systematic review and meta-analysis",
        "Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases",
        "Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma",
        "GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population",
        "Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)",
        "AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.",
        "Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre study",
        "Hepatology",
        "Hepatology",
        "Dickkopf-1: As a diagnostic and prognostic serum marker for early hepatocellular carcinoma",
        "Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence",
        "Hepatology",
        "Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma",
        "Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma",
        "The microRNA-200 family - A potential diagnostic marker in hepatocellular carcinoma?",
        "Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma",
        "Serum miR-18a: A potential marker for hepatitis B virus-related hepatocellular carcinoma screening",
        "Hepatocellular carcinoma in the noncirrhotic liver",
        "Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma",
        "Unique genomic profile of fibrolamellar hepatocellular carcinoma",
        "Genomic analysis of fibrolamellar hepatocellular carcinoma",
        "A systematic review: Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma",
        "Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma",
        "Diagnosis and management of primary sclerosing cholangitis",
        "Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis",
        "Classification, Diagnosis, and Management of Cholangiocarcinoma",
        "Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma",
        "Cancer surveillance in patients with primary sclerosing cholangitis",
        "Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma",
        "Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma",
        "Identification of targetable FGFR gene fusions in diverse cancers",
        "Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma",
        "The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis",
        "Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis",
        "Cholangiocarcinoma",
        "Biomarkers in cholangiocarcinoma",
        "A new clinically based staging system for perihilar cholangiocarcinoma",
        "Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA",
        "FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology",
        "A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures",
        "Comparison of methods to detect neoplasia in patients undergoing endoscopic ultrasound-guided fine-needle aspiration",
        "A Multivariable Model Using Advanced Cytologic Methods for the Evaluation of Indeterminate Pancreatobiliary Strictures",
        "Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: A molecular test with proven clinical success",
        "Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography",
        "Primary sclerosing cholangitis with equivocal cytology: Fluorescence in situ hybridization and serum ca 19-9 predict risk of malignancy",
        "Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: A systematic review and meta-analysis",
        "Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Center for Advancing Translational Sciences",
        "National Institutes of Health"
    ]
}